References
- 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
- 2. McNeil BK, Getzenberg RH. Urine-based markers in bladder cancer: future prospects. BJU Int. 2008; 101: 668-9.
- 3. Sriplung S. Urinary bladder. In Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P eds,. Cancer in Thailand Vol IV 1998-2000 Bangkok: Bangkok Medical Publisher, 2007: p. 61-2.
- 4. Sanchez-Carbayo M. Recent advances in bladder cancer diagnostics. Clin Biochem. 2004; 37:562-71.
- 5. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: a minireview. Glycoconj J. 2004; 20: 189-98.
- 6. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J. 2004; 20:353-64.
- 7. Crook M. The determination of plasma or serum sialic acid. Clin Biochem. 1993; 26:31-38.
- 8. Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci. 1994; 24:376-84.
- 9. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest. 1999; 29:413-25.10.1046/j.1365-2362.1999.00485.x
- 10. Patel PS, Baxi BR, Adhvaryu SG, Balar DB. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 1990; 10:1071-4.
- 11. Feijoo C, Paez de la Cadena M, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Sialic acid levels in serum and tissue from colorectal cancer patients. Cancer Lett. 1997; 112:155-60.
- 12. Wongkham S, Boonla C, Kongkham S, Wongkham C, Bhudhisawasdi V, Sripa B. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin Biochem. 2001; 34:537-41.10.1016/S0009-9120(01)00265-X
- 13. Hobarth K, Hofbauer J, Fang-Kircher S. Plasma sialic acid in patients with prostate cancer. Br J Urol. 1993; 72:621-4.
- 14. Dunzendorfer U, Katopodis N, Dnistrian AM, Stock CC, Schwartz MK, Whitmore WF, Jr. Plasma lipid bound sialic acid in patients with prostate and bladder cancer. Invest Urol. 1981; 19:194-6.
- 15. Oztokatli A, Ozkardes H, Ovul E, Erol D. The significance of serum lipid-bound sialic acid in bladder tumours. Int Urol Nephrol. 1992; 24:125-9.10.1007/BF02549639
- 16. Lagana A, Pardo-Martinez B, Marino A, Fago G, Bizzarri M. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker. Clin Chim Acta. 1995; 243: 165-79.
- 17. Akcay T, Konukoglu D, Erosenci A, Ataus S, Dirican A, Uygur C. Urinary excretion of sialic acid in patients with superficial bladder tumors. Cancer Lett. 1994; 78: 7-9.10.1016/0304-3835(94)90024-8
- 18. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004; 44:239-67.10.1146/annurev.pharmtox.44.101802.121851
- 19. Akcay T, Saygili I, Andican G, Yalcin V. Increased formation of 8-hydroxy-2'-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int. 2003; 71:271-4.
- 20. Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta. 2003; 334:87-94.
- 21. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol. 2010; 28:360-7.10.1016/j.urolonc.2008.12.010
- 22. Hoogwerf BJ, Laine DC, Greene E. Urine C-peptide and creatinine (Jaffe method) excretion in healthy young adults on varied diets: sustained effects of varied carbohydrate, protein, and meat content. Am J Clin Nutr. 1986; 43:350-60.10.1093/ajcn/43.3.350
- 23. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961; 81: 384-92.10.1042/bj0810384
- 24. Marshall PJ, Warso MA, Lands WE. Selective microdetermination of lipid hydroperoxides. Anal Biochem. 1985; 145:192-9.
- 25. Taylor JA, 3rd, Kuchel GA. Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat Clin Pract Urol. 2009; 6:135-44.10.1038/ncpuro1315
- 26. Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009; 4:251-85.
- 27. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res. 2009; 674:85-92.
- 28. Konety BR, Getzenberg RH. Urine based markers ofurological malignancy. J Urol. 2001; 165:600-11.
- 29. Konukoglu D, Akcay T, Celik C, Erozenci A. Urinary excretion of sialic acid in patients with bladder tumors. Cancer Lett. 1995; 94:97-100.
- 30. Basoglu M, Atamanalp SS, Yildirgan MI, Aydinli B, Ozturk G, Akcay F, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007; 39:136-40.
- 31. Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, et al. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. J Exp Ther Oncol. 2006; 5:223-9.
- 32. Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, et al. Five tumor markers in lung cancer: significance of total and “lipid”-bound sialic acid. Anticancer Res. 1991; 11:2107-10.
- 33. Reganon E, Vila V, Martinez-Sales V, Vaya A, Mira Y, Ferrando F, et al. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis. Thromb Res. 2007; 119:73-8.
- 34. Ekin S, Mert N, Gunduz H, Meral I. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2003; 94:193-201.10.1385/BTER:94:3:193
- 35. Goswami K, Nandeesha H, Koner BC, Nandakumar DN. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis. Prostate Cancer Prostatic Dis. 2007; 10:356-59.
- 36. Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004; 93:863-6.10.1111/j.1464-410X.2003.04729.x
- 37. Arikan S, Akcay T, Konukoglu D, Obek C, Kural AR. The relationship between antioxidant enzymes and bladder cancer. Neoplasma. 2005; 52:314-7.
- 38. Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol. 2002; 156:1002-10.
- 39. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004; 21:392-401.
- 40. Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett. 2008; 264:299-308.
- 41. Patumraj S, Yoisungneon P. Curcumin as a therapeutic agent against cancer. Asian Biomed. 2007; 1:239-52.
- 42. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006; 7:766-74.10.1016/S1470-2045(06)70862-2
- 43. Kurtul N, Cil MY, Pacaci SD. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maras powder). J Biomed Sci. 2005; 12:559-63.10.1007/s11373-005-4563-x